4-Chloro-2-(2,2,2-trifluoroethyl)-2H-pyrazolo[3,4-d]pyrimidine

Catalog No. :
ACUNRI890
CAS No. :
1450917-13-1
Molecular Formula :
C7H4ClF3N4
Molecular Weight :
236.58

IUPAC Name:4-chloro-2-(2,2,2-trifluoroethyl)-2H-pyrazolo[3,4-d]pyrimidine

4-Chloro-2-(2,2,2-trifluoroethyl)-2H-pyrazolo[3,4-d]pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$141.00Login to see priceInquiryInquiry
250mg98%$201.00Login to see priceInquiryInquiry
1g98%$404.00Login to see priceInquiryInquiry
5g98%$1619.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Chloro-2-(2,2,2-trifluoroethyl)-2H-pyrazolo[3,4-d]pyrimidine
IUPAC Name4-chloro-2-(2,2,2-trifluoroethyl)-2H-pyrazolo[3,4-d]pyrimidine
Molecular FormulaC7H4ClF3N4
Molecular Weight236.58
SMILESFC(F)(F)CN1N=C2N=CN=C(Cl)C2=C1
InChI KeyYUJKZOASOMFGNM-UHFFFAOYSA-N
Synonym4-Chloro-2-(2,2,2-trifluoroethyl)-2H-pyrazolo[3,4-d]pyrimidine;2H-Pyrazolo[3,4-d]pyrimidine, 4-chloro-2-(2,2,2-trifluoroethyl)-
CAS No.1450917-13-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACUNRI890 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTYHX731 route compound structure diagram
    ACTYHX7315399-92-8 In Stock
  4. Then
  5. ACUNRI890 route product structure diagram
    ACUNRI8901450917-13-1
Inquiry

2. ACUNRI890 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTYHX731 route compound structure diagram
    ACTYHX7315399-92-8 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUNRI890 route product structure diagram
    ACUNRI8901450917-13-1
Inquiry

Comments (0)